Generics 1

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Nelarabine manufacturers

1 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

1 products found

nelarabine

Injection 5 mg/ml

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
WHO
Manufacturer #34252

Manufacturer usually replies in 2 days

Want to see all 1 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

NELARABINE Manufacturer

Nelarabine is a medical substance also known as purine nucleoside analog and antineoplastic agent that is used for the treatment of acute T-cell lymphoblastic leukemia and T-cell lymphoblastic lymphoma with inadequate clinical response to prior chemotherapeutic treatments. Warnings: Follow all Instructions on your medicine package and label. It is wise to tell your healthcare providers about all your medical allergies, illnesses, and all medicines you use. Before taking Nelarabine: You should not use This medical remedy if you are allergic to it This drug may also be used for purposes that may not have been listed in this medication guide.

How does NELARABINE work?

Once nelarabine is metabolized into ara-GTP, the metabolite masses in leukemic impacts and consolidates into DNA to apply its S phase-specific cytotoxic impacts, driving to the acceptance of fracture and apoptosis. Extra cytotoxic exercises may exist, but these are not completely understood.

How much money does NELARABINE cost?

It is obtainable in generic and brand versions. It is not covered by most Medicare and insurance plans, but pharmacy coupons can help balance the price. The cost for levocetirizine memantine is around $777 for a supply of 50 milliliters. Prices may vary depending on the pharmacy you visit.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of NELARABINE offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for NELARABINE manufacturers and NELARABINE suppliers that you are looking for. These also enable you to check the dossier status , and the GMP approvals of the different variants. Also, each manufacturer or supplier product description contains essential information about NELARABINE including clinical data, stability zones, countries where NELARABINE is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over Ivermectin offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that Ivermectin manufacturers have, we qualify their companies before they are boarded on the platform. This allows us to screen Ivermectin manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation